1
|
Paduano F, Colao E, Grillone T, Vismara MFM, Amato R, Nisticò S, Mignogna C, Dastoli S, Fabiani F, Zucco R, Trapasso F, Perrotti N, Iuliano R. A Familial Form of Epidermolysis Bullosa Simplex Associated with a Pathogenic Variant in KRT5. Genes (Basel) 2021; 12:genes12101503. [PMID: 34680898 PMCID: PMC8535670 DOI: 10.3390/genes12101503] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 09/16/2021] [Accepted: 09/19/2021] [Indexed: 12/21/2022] Open
Abstract
Epidermolysis bullosa simplex is a disease that belongs to a group of genodermatoses characterised by the formation of superficial bullous lesions caused by minor mechanical trauma to the skin. The skin fragility observed in the EBS is mainly caused by pathogenic variants in the KRT5 and KRT14 genes that compromise the mechanical stability of epithelial cells. By performing DNA sequencing in a female patient with EBS, we found the pathogenic variant c.967G>A (p.Val323Met) in the KRT5 gene. This variant co-segregated with EBS in the family pedigree and was transmitted in an autosomal dominant inheritance manner. This is the first report showing a familial form of EBS due to this pathogenic variant.
Collapse
Affiliation(s)
- Francesco Paduano
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
- Tecnologica Research Institute and Marrelli Health, Biomedical Section, Stem Cells and Medical Genetics Units, 88900 Crotone, Italy
- Correspondence: (F.P.); (R.I.)
| | - Emma Colao
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
| | - Teresa Grillone
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
| | - Marco Flavio Michele Vismara
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
| | - Rosario Amato
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
| | - Steven Nisticò
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
| | - Chiara Mignogna
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
| | - Stefano Dastoli
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
| | - Fernanda Fabiani
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
| | - Rossella Zucco
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
| | - Francesco Trapasso
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
- Department of Experimental and Clinical Medicine, Campus S. Venuta, University Magna Graecia of Catanzaro, Viale Europa, 88100 Catanzaro, Italy
| | - Nicola Perrotti
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
| | - Rodolfo Iuliano
- Medical Genetics Unit, Mater Domini University Hospital, 88100 Catanzaro, Italy; (E.C.); (T.G.); (M.F.M.V.); (R.A.); (F.F.); (F.T.); (N.P.)
- Department of Health Sciences, Campus S. Venuta, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; (S.N.); (C.M.); (S.D.); (R.Z.)
- Correspondence: (F.P.); (R.I.)
| |
Collapse
|
2
|
Abstract
Innate immunity plays a central role in neoplasms, including those affecting the central nervous system (CNS). Nowadays, tumors classification, especially that regarding gliomas, is based on molecular features such as mutations in isocitrate dehydrogenase (IDH) genes and the presence of co-deletion 1p/19q. Therapy, in most cases, is based on surgery, radiotherapy, and pharmacological treatment with chemotherapeutic agents such as temozolomide. However, the results of the treatments, after many decades, are not completely satisfactory. There is a class of drugs, used to treat cancer, which modulates immune response; in this class, the immune checkpoint inhibitors and vaccines play a prominent role. These drugs were evaluated for the treatment of gliomas, but they exhibited a poor outcome in clinical trials. Those scarce results could be due to the response of tumor-associated macrophage that creates imbalances between innate and adaptive immunity and changes in blood–brain barrier properties. Here, we have briefly reviewed the current literature on this topic, focusing on the possible role for innate immunity in the failure of immunotherapies against brain tumors.
Collapse
Affiliation(s)
| | - Annalidia Donato
- 2 Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia," Catanzaro, Italy
| | - Natalia Malara
- 3 Department of Clinical and Experimental Medicine, University of Catanzaro "Magna Graecia," Catanzaro, Italy
| | - Ivan Presta
- 4 Department of Health Sciences, University of Catanzaro "Magna Graecia," Catanzaro, Italy
| | - Giuseppe Donato
- 4 Department of Health Sciences, University of Catanzaro "Magna Graecia," Catanzaro, Italy
| |
Collapse
|
3
|
Vismara MFM, Toaff J, Pulvirenti G, Settanni C, Colao E, Lavano SM, Cemicetti R, Cotugno D, Perrotti G, Meschesi V, Montera R, Zepponi B, Rapetto U, Marotta R. Internet Use and Access, Behavior, Cyberbullying, and Grooming: Results of an Investigative Whole City Survey of Adolescents. Interact J Med Res 2017; 6:e9. [PMID: 28851675 PMCID: PMC5596301 DOI: 10.2196/ijmr.6231] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2016] [Revised: 01/17/2017] [Accepted: 01/31/2017] [Indexed: 11/13/2022] Open
Abstract
Background According to the Digital Agenda for Europe, the way children use the Internet and mobile technologies has changed dramatically in the past years. Objective The aims of this study were to: (1) breakdown the modalities of access and use of the Internet by teenagers to assess risks and risky behaviors; and (2) provide scientific data to evaluate and counsel safe use of the Internet and new technologies by teenagers. Methods The study was conducted under the program “Strategies for a Better Internet for Children” started in May 2012 by the European Commission. It represents the main result of the project launched by Telecom Italia, “Anche io ho qualcosa da dire” (I too have something to say), thanks to which many contributions were collected and used to develop a survey. The questionnaire was structured in 45 questions, covering three macro areas of interest. It was approved by the Department Board at University of Magna Graecia’s School of Medicine. After authorization from the regional high school authority, it was administered to all 1534 students (aged 13-19 years) in the city of Catanzaro, Italy. Results The data was broken down into three main groups: (1) describing education and access to the Internet; (2) methods of use and social networking; and (3) perception and evaluation of risk and risky behaviors. Among noteworthy results in the first group, we can mention that the average age of first contact with information technologies was around 9 years. Moreover, 78.87% (1210/1534) of the interviewed students reported having access to a smartphone or a tablet. Among the results of the second group, we found that the most used social networks were Facebook (85.78%, 1316/1534), YouTube (61.14%, 938/1534), and Google+ (51.56%, 791/1534). About 71.31% (1094/1534) of the interviewed teenagers use their name and surname on social networks, and 40.09% (615/1534) of them knew all their Facebook contacts personally. Among the results of the third group, we found that 7.69% (118/1534) of the interviewed teenagers have uploaded pictures or movies of which they felt ashamed; 27.05% (415/1534) have received invitations from people they met on the Internet to meet in real life; and 8.67% (133/1534) have accepted such invitations. Conclusions The results offer a breakdown of the teenagers’ use of the Internet, focusing on how teenagers learn to use and access it while taking into account factors such as parental coaching, schooling, or self-education. It describes how they approach and interact with social networks and how they perceive risks and risky behaviors on the Internet. Information technology must be seen as an instrument and not as a hindrance. For this to happen, parental guidance, schooling, and medical counseling are needed for a sound development of the child in this critical stage.
Collapse
Affiliation(s)
- Marco Flavio Michele Vismara
- Graduate School of Medical Genetics XXVI Cycle, Dipartimento di Medicina Sperimentale della Facoltà di Medicina e Odontoiatria, Sapienza University, Rome, Italy
| | - Joseph Toaff
- Communication Science and Media Consulting, Versailles, France
| | - Giuliana Pulvirenti
- Dipartimento di Scienze Cognitive, Psicologiche, Pedagogiche e degli Studi Culturali, University of Messina, Messina, Italy
| | | | - Emma Colao
- Medical Genetics Unit, Mater Domini University Hospital, Catanzaro, Italy
| | - Serena Marianna Lavano
- Dipartimento di Scienze della Salute, Life Science and Technology Graduate School, Magna Graecia University, Catanzaro, Italy
| | | | | | - Giuseppe Perrotti
- Faculty of Veterinary Medicine, Federico II University, Naples, Italy
| | | | - Roberto Montera
- Department of Obstetrics and Gynecology, Magna Graecia University of Catanzaro, Catanzaro, Italy.,Department of Obstetrics and Gynecology, Campus Bio-Medico University of Rome, Rome, Italy
| | | | | | - Rosa Marotta
- Dipartimento di Scienze Mediche e Chirurgiche, Magna Graecia University, Catanzaro, Italy.,Unità Operativa Complessa di Pediatria Universitaria, Azienda Ospedaliera "Pugliese-Ciaccio", Catanzaro, Italy
| |
Collapse
|
4
|
Grillone T, Menniti M, Bombardiere F, Vismara MFM, Belviso S, Fabiani F, Perrotti N, Iuliano R, Colao E. New SLC12A3 disease causative mutation of Gitelman’s syndrome. World J Nephrol 2016; 5:551-555. [PMID: 27872838 PMCID: PMC5099602 DOI: 10.5527/wjn.v5.i6.551] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2016] [Revised: 07/21/2016] [Accepted: 09/22/2016] [Indexed: 02/06/2023] Open
Abstract
Gitelman’s syndrome (GS) is a salt-losing tubulopathy with an autosomal recessive inheritance caused by mutations of SLC12A3, which encodes for the thiazide-sensitive NaCl cotransporter. In this study we report a new mutation of SLC12A3 found in two brothers affected by GS. Hypokalemia, hypocalciuria and hyper-reninemia were present in both patients while hypomagnesemia was detected only in one. Both patients are compound heterozygotes carrying one well known GS associated mutation (c.2581 C > T) and a new one (c.283delC) in SLC12A3 gene. The new mutation results in a possible frame-shift with a premature stop-codon (pGln95ArgfsX19). The parents of the patients, heterozygous carriers of the mutations found in SLC12A3, have no disease associated phenotype. Therefore, the new mutation is causative of GS.
Collapse
|
5
|
Mignogna C, Signorelli F, Vismara MFM, Zeppa P, Camastra C, Barni T, Donato G, Di Vito A. A reappraisal of macrophage polarization in glioblastoma: Histopathological and immunohistochemical findings and review of the literature. Pathol Res Pract 2016; 212:491-9. [DOI: 10.1016/j.prp.2016.02.020] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/23/2015] [Revised: 01/28/2016] [Accepted: 02/23/2016] [Indexed: 12/22/2022]
|